Scarica l'app Stockscreener
79.29
2.04%
-1.65
Dopo l'orario di chiusura:
78.88
-0.41
-0.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$80.94
Aprire:
$79.86
Volume 24 ore:
262.74K
Relative Volume:
0.45
Capitalizzazione di mercato:
$2.99B
Reddito:
-
Utile/perdita netta:
$-91.00M
Rapporto P/E:
-21.60
EPS:
-3.67
Flusso di cassa netto:
$-74.38M
1 W Prestazione:
-0.15%
1M Prestazione:
-14.04%
6M Prestazione:
+49.69%
1 anno Prestazione:
+26.78%
Intervallo 1D:
$78.00
$81.90
Intervallo di 1 settimana:
$76.19
$81.90
Portata 52W:
$30.82
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Confronta IRON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
79.29 | 3.06B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Ripresa | Stifel | Buy |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-11 | Ripresa | Raymond James | Strong Buy |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Will Disc Medicine Inc. stock deliver strong dividend growthWeekly Trend Recap & Detailed Earnings Play Strategies - ulpravda.ru
How institutional buying supports Disc Medicine Inc. stockJuly 2025 Technicals & Technical Entry and Exit Tips - ulpravda.ru
How supply chain issues affect Disc Medicine Inc. stockWeekly Trading Summary & Intraday High Probability Setup Alerts - ulpravda.ru
Aug Selloffs: Why Disc Medicine Inc. stock is favored by top institutionsJuly 2025 Opening Moves & Growth Oriented Trade Recommendations - ulpravda.ru
Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Why Disc Medicine Inc. stock is seen as undervalued2026 world cup usa national team round of 16 young talents transition play winner prediction tactical review - ulpravda.ru
Disc Medicine, Inc. (IRON) Stock Analysis: Strong Buy Ratings and a Promising 54.73% Potential Upside - DirectorsTalk Interviews
Disc Medicine (NASDAQ:IRON) Insider Sells $511,485.00 in Stock - MarketBeat
Aug Catalysts: Will Disc Medicine Inc stock deliver strong dividend growth2025 Retail Activity & Safe Entry Momentum Tips - moha.gov.vn
Disc Medicine: RALLY-MF Data Validates Pipeline Optionality (NASDAQ:IRON) - Seeking Alpha
Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus - TechStock²
Precision Trading with Disc Medicine Inc. (IRON) Risk Zones - Stock Traders Daily
Disc Medicine, Inc. (IRON) Stock Analysis: Poised for 55% Upside Potential Amid Robust Analyst Confidence - DirectorsTalk Interviews
Disc Medicine Earnings Notes - Trefis
Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Disc Medicine (IRON) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Moderna (MRNA) and Disc Medicine (IRON) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), Disc Medicine (IRON) and BioMarin Pharmaceutical (BMRN) - The Globe and Mail
Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy - BioSpace
Avoiding Lag: Real-Time Signals in (IRON) Movement - news.stocktradersdaily.com
Breakouts Watch: Is Disc Medicine Inc. stock attractive for hedge fundsRisk Management & Free Growth Oriented Trading Recommendations - Улправда
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next - ts2.tech
Breakout Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatRisk Management & Technical Confirmation Trade Alerts - Улправда
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Can Disc Medicine Inc. stock deliver consistent earnings growthJuly 2025 Levels & Risk Controlled Swing Trade Alerts - Улправда
Stifel reaffirms Buy rating on Disc Medicine stock amid FDA review speculation - Investing.com Canada
Jefferies reiterates Buy rating on Disc Medicine stock amid FDA concerns - Investing.com Canada
Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’ - Asianet Newsable
Disc Medicine (IRON) Gains Confidence Despite Timeline Concerns - GuruFocus
Disc Medicine stock rating reiterated at Outperform by BMO amid FDA review - Investing.com
Disc Medicine (IRON) Maintains Positive Outlook Amid CNPV Skepti - GuruFocus
Disc Medicine drops on report of FDA skepticism over rare blood disorder drug - TradingView — Track All Markets
Disc Medicine (NASDAQ: IRON) Stock Tumbles on Insider-Selling Headlines as Bitopertin FDA Decision Nears — News, Analyst Forecasts, and What to Watch (Dec. 19, 2025) - ts2.tech
Disc Medicine Enters Oversold Territory (IRON) - Nasdaq
Disc Medicine (IRON) Shares Decline Over 14% - GuruFocus
FDA Fast-Track Review Challenges Impact Disc Medicine's (IRON) B - GuruFocus
Disc Medicine (NASDAQ:IRON) Shares Down 9% After Insider Selling - MarketBeat
Is Disc Medicine Inc. stock a buy before product launchesRate Hike & Expert Approved Momentum Trade Ideas - DonanımHaber
Aug Movers: Why Disc Medicine Inc stock is seen as undervalued2025 Earnings Impact & Capital Efficient Trading Techniques - moha.gov.vn
Downgrade Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatJuly 2025 Recap & Daily Profit Focused Screening - Улправда
Disc Medicine (NASDAQ:IRON) Director Sells $68,968.38 in Stock - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Short Covering: How analysts rate Disc Medicine Inc. stock todayFed Meeting & Weekly Setup with ROI Potential - Улправда
Hedge Fund Moves: Is Disc Medicine Inc. stock recession proofProduct Launch & Entry Point Confirmation Signals - Улправда
Is Disc Medicine Inc. stock attractive for hedge fundsChart Signals & Precise Swing Trade Entry Alerts - Bollywood Helpline
Disc Medicine Insider Sold Shares Worth $16,858,639, According to a Recent SEC Filing - marketscreener.com
Disc Medicine Insider Sold Shares Worth $1,194,372, According to a Recent SEC Filing - marketscreener.com
Kevin Bitterman Sells 62,693 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine (NASDAQ:IRON) Insider William Jacob Savage Sells 13,093 Shares - MarketBeat
Insider Sell: William Savage Sells 13,093 Shares of Disc Medicine Inc (IRON) - GuruFocus
IRON Receives Updated Overweight Rating and Raised Price Target from Wells Fargo | IRON Stock News - GuruFocus
Disc Medicine (NASDAQ:IRON) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):